Intensity Therapeutics, Inc. (INTS)
NASDAQ: INTS · Real-Time Price · USD
1.911
-0.039 (-2.02%)
Mar 31, 2025, 10:32 AM EDT - Market open
Intensity Therapeutics Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for Intensity Therapeutics stock have an average target of 8.50, with a low estimate of 5.00 and a high estimate of 12. The average target predicts an increase of 344.86% from the current stock price of 1.91.
Analyst Consensus: Strong Buy
* Price targets were last updated on Jan 13, 2025.
Analyst Ratings
The average analyst rating for Intensity Therapeutics stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 |
---|---|---|---|---|---|---|
Strong Buy | 1 | 1 | 1 | 2 | 2 | 2 |
Buy | 1 | 1 | 1 | 1 | 1 | 1 |
Hold | 0 | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 2 | 2 | 2 | 3 | 3 | 3 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Alliance Global Partners | Alliance Global Partners | Strong Buy Initiates $8.5 | Strong Buy | Initiates | $8.5 | +344.86% | Jan 13, 2025 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $5 | Strong Buy | Reiterates | $5 | +161.68% | Nov 21, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $5 | Strong Buy | Initiates | $5 | +161.68% | Oct 31, 2024 |
Benchmark | Benchmark | Buy Reiterates $12 | Buy | Reiterates | $12 | +528.04% | Jul 11, 2024 |
Benchmark | Benchmark | Buy Reiterates $12 | Buy | Reiterates | $12 | +528.04% | May 16, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-0.86
from -1.17
EPS Next Year
-0.64
from -0.86
Revenue Forecast
Revenue | 2025 | 2026 | 2028 | 2029 |
---|---|---|---|---|
High | n/a | 6.3M | 115.8M | |
Avg | n/a | 2.0M | 60.6M | |
Low | n/a | n/a | 8.3M |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2028 | 2029 |
---|---|---|---|---|
High | - | - | 5,578.4% | |
Avg | - | - | 2,869.9% | |
Low | - | - | 306.8% |
EPS Forecast
EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | -0.59 | -0.47 | -0.41 | ||
Avg | -0.86 | -0.64 | -0.58 | ||
Low | -1.04 | -0.78 | -0.74 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | - | - | - | ||
Avg | - | - | - | ||
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.